Phase 2 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age (inclusive)
- People who have a current diagnosis of Major Depressive Disorder (MDD), confirmed through a structured psychiatric interview called the MINI
- People whose depression symptoms score at least 16 on a standard rating scale called the HAM-D17, indicating a moderate to severe level of symptoms
- People who have been consistently taking an antidepressant (specifically an SSRI or SNRI) approved by the FDA for at least 8 weeks
- People who are right-handed
- People who have been living at an altitude above 4,000 feet for at least 12 weeks
Who may not be able to join:
- People who have a psychiatric diagnosis other than MDD or an anxiety disorder, as identified by the MINI interview
- People with a history of or current kidney disease, such as chronic kidney failure, acute kidney failure, or end-stage kidney disease
- People who currently have colitis or diverticulitis (inflammatory conditions of the bowel)
- People with a history of or current lung disease (except for well-controlled asthma)
- People who currently smoke
- People with a history of heart disease, or whose heart's electrical activity shows a specific measurement (QTc) greater than 500ms on a heart tracing (confirm with trial site)
- People with a history of fibromyalgia or any rheumatological (joint or autoimmune) condition
- People with a history of or current seizure disorder
- People who are currently assessed as having a serious risk of suicide, based on a standard rating scale
- People who are currently taking antipsychotics, mood stabilisers, or antidepressants other than SSRIs or SNRIs — with the exception of bupropion at FDA-approved doses or trazodone up to 200mg — or who are taking any supplements other than standard multivitamins
- People who are pregnant, have tested positive on a pregnancy test, or are not using an adequate method of birth control
- People who have previously been diagnosed with serotonin syndrome, or who show signs of it currently (a potentially serious reaction to certain medications)
- People with a pre-existing elevated level of a specific type of white blood cell called eosinophils (above 500 per microlitre of blood)
- People who are unable to have an MRI scan, including those with certain metal implants or implanted devices, or those with severe claustrophobia (fear of enclosed spaces)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8015851418
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
17-Item Hamilton Depression Rating Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.